Zobrazeno 1 - 10
of 44
pro vyhledávání: '"K Sh Gantsev"'
Autor:
B P Matveev, O B Karyakin, V B Matveev, Yu G Alyaev, I G Rusakov, A Z Vinarov, B V Bukharkin, L V Shaplygin, B Ya Alekseev, V A Biryukov, S V Galanin, V P Izgeym, A V Lykov, Yu N Khrizman, K Sh Gantsev, P A Karnaukh
Publikováno v:
Современная онкология, Vol 6, Iss 3, Pp 111-113 (2004)
Рак предстательной железы (РПЖ) - одно из наиболее распространенных заболеваний у мужчин пожилого возраста. При наличии костных метаста
Externí odkaz:
https://doaj.org/article/36beef7336064c80815d888dc1b3898c
Autor:
K. R. Ishmuratova, K. Sh. Gantsev
Publikováno v:
Креативная хирургия и онкология, Vol 12, Iss 4, Pp 328-336 (2023)
Peritoneal metastasis occurs in a number of heterogeneous tumors originating from the ovaries, stomach, intestines, pancreas, lungs, breast, and melanoma. Peritoneal carcinomatosis significantly reduces overall survival. While being almost unresponsi
Externí odkaz:
https://doaj.org/article/a0500cfdaf5e40158a1fda701c844257
Autor:
Sh. Kh. Gantsev, G. Schaller, K. Sh. Gantsev, A. N. Plikhta, Sh. R. Kzyrgalin, R. A. Rustamkhanov
Publikováno v:
Креативная хирургия и онкология, Vol 11, Iss 2, Pp 144-148 (2021)
Introduction. Neuroendocrine breast tumors represent a rare subtype of breast cancer, accounting for less than 1 % of all neuroendocrine neoplasms. Starting from their pathology definition, and going through their prevalence, prognosis and treatment,
Publikováno v:
Креативная хирургия и онкология, Vol 11, Iss 2, Pp 149-156 (2021)
Peritoneal carcinomatosis is viewed by many experts as a terminal illness with an unfavourable course and prognosis. Existing therapies are controversial and exhibit ambiguous efficacy. We review the current state of the art in therapy for peritoneal
Publikováno v:
Креативная хирургия и онкология, Vol 11, Iss 1, Pp 85-91 (2021)
Peritoneal carcinomatosis (PC) is a global challenge of modern oncology representing the most unfavourable scenario in diverse-locality tumourisation. Despite certain attention by the oncological community, the management of PC patients is currently
Publikováno v:
Креативная хирургия и онкология, Vol 10, Iss 3, Pp 217-220 (2020)
Introduction. Chemotherapy in the form of endovascular infusion or its combination with radiotherapy is a method for treating non-small cell lung cancer (NSCLC), which raises heated discussions among specialists. This study is aimed at assessing the
Autor:
S. Kh. Gantsev, V. V. Starinsky, A. M. Belyaev, O. N. Lipatov, K. Sh. Gantsev, S. R. Kzyrgalin, D. S. Tursumetov, Е. R. Ivanova, A. Kh. Gainullin
Publikováno v:
Креативная хирургия и онкология, Vol 10, Iss 1, Pp 74-81 (2020)
The establishment of oncology as a discipline in Russia should be considered taking into account the specifics of national history, as well as key historical events. In 2020, Russia celebrates the 75th anniversary of Victory in the Great Patriotic Wa
Publikováno v:
Креативная хирургия и онкология, Vol 9, Iss 4, Pp 293-296 (2020)
This brief review is devoted to the role of tertiary lymphoid structures in oncological processes. A number of research studies carried out over the past ten years have shed light on the functions of such structures in various diseases, as well as th
Autor:
Sh. R. Kzyrgalin, O. V. Zayratyants, Rasul A. Rustamkhanov, O. N. Lipatov, R. S. Sufiyarov, K. Sh. Gantsev, Sh. H. Gantsev
Publikováno v:
Health Care of the Russian Federation. 63:108-112
The issues of medical statistics on mortality from cancer, especially the correctness of such indicators, attract general interest. In a comparative aspect, mortality rates in different countries are given and the possible influence of various factor
Autor:
K. Sh. Gantsev, A. A. Khmelevskiy
Publikováno v:
Креативная хирургия и онкология, Vol 8, Iss 4, Pp 263-267 (2019)
Introduction. Despite the fact that the combined use of bevacizumab and interferon α -2A has been studied extensively and proved to be safe, there will always remain a group of patients for whom continuing the long-term drug treatment after a radica